More than 50% Reduction of Restenosis Rate Compared to Standard PTA LEIPZIG, Germany–(HSMN NewsFeed)–Invatec, a comprehensive innovator of interventional products, welcomed the first clinical results of the Drug Eluting Balloon (DEB), IN.PACT Amphirio…
Devices, Interventional
Invatec, Drug Eluting Balloon, IN.PACT Amphirion, Critical Limb Ischemia

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Invatec Comments on First Clinical Results of Drug Eluting Balloon Technology for Below the Knee (BtK)”
Leave a Comment